Workflow
American Tungsten Upsizes Non-Brokered LIFE Private Placement to $20 Million
aTyr PharmaaTyr Pharma(US:LIFE) Newsfileยท2025-10-15 22:49

Core Viewpoint - American Tungsten Corp. has increased its non-brokered Listed Issuer Financing Exemption (LIFE) private placement offering to raise up to $22.6 million due to strong investor demand [1][4]. Group 1: Offering Details - The upsized offering will consist of up to 6,468,572 common shares priced at $3.50 each, issued under the LIFE exemption [2]. - Shares issued under the LIFE exemption will not be subject to a statutory hold period under Canadian securities laws [2]. - The Company may pay cash finders' fees of up to 6.0% of the gross proceeds raised from subscribers introduced by eligible finders [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to accelerate the development timeline, support the transition toward production, and fund the upcoming exploration program at the IMA Mine [4]. - The Company aims to reinforce its vision of becoming the leading U.S. supplier of tungsten [4]. Group 3: Company Overview - American Tungsten Corp. is focused on high-potential tungsten and magnetite assets in North America, particularly advancing the Ima Mine Project in Idaho [6]. - The Ima Mine Project is a historic underground tungsten property with significant infrastructure, and the Company holds an exclusive option to acquire full ownership [6].